Gannon Steven insider trades
Gannon Steven has filed 16 Form 4s with the SEC that we hold, for Xenon Pharmaceuticals Inc. (XENE) (Director) and FUSN (Director). Across all of them we count 5 purchases worth $186.9K and 6 sales worth $1.2M reported on Form 4. In the last 12 months: 0 purchases ($0) and 1 sale ($640.5K). The largest single trade was a sale of 10,000 shares of Xenon Pharmaceuticals Inc. worth $640.5K, dated 2026-08-11. The first filing on our record is dated 2021-08-17 and the latest 2026-08-13.
Xenon Pharmaceuticals Inc. (XENE)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2024-03-07 | S, sale reported on Form 4 | 5,000 | $231.5K | 2024-03-08 |
| 2024-03-07 | S, sale reported on Form 4 | 5,000 | $231.2K | 2024-03-08 |
| 2024-03-07 | S, sale reported on Form 4 | 2,000 | $92.4K | 2024-03-08 |
| 2024-03-07 | S, sale reported on Form 4 | 1,000 | $46.5K | 2024-03-08 |
| 2025-06-05 | S, sale reported on Form 4 | 3 | $91 | 2025-06-06 |
| 2026-08-11 | S, sale reported on Form 4 | 10,000 | $640.5K | 2026-08-13 |
FUSN
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2021-08-16 | P, purchase reported on Form 4 | 6,000 | $48.6K | 2021-08-17 |
| 2021-08-18 | P, purchase reported on Form 4 | 171 | $1.4K | 2021-08-20 |
| 2021-08-19 | P, purchase reported on Form 4 | 3,000 | $24.2K | 2021-08-20 |
| 2021-08-23 | P, purchase reported on Form 4 | 2,829 | $22.6K | 2021-08-23 |
| 2022-08-11 | P, purchase reported on Form 4 | 44,400 | $90.1K | 2022-08-11 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1643085) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms